$FXF
Invesco CurrencyShares Swiss Franc Trust

2023 Q1 Form 10-Q Financial Statement

#000095017023019017 Filed on May 09, 2023

View on sec.gov

Income Statement

Concept 2023 Q1 2022 Q1
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin
YoY Change
% of Gross Profit
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $205.4K $699.1K
YoY Change -70.62% -19.87%
Operating Profit
YoY Change
Interest Expense $0.00 $458.2K
YoY Change -100.0% -19.87%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income
YoY Change
Income Tax $0.00 $0.00
% Of Pretax Income
Net Earnings -$205.4K -$699.1K
YoY Change -70.62% -19.87%
Net Earnings / Revenue
Basic Earnings Per Share -$0.10 -$0.08
Diluted Earnings Per Share -$0.10 -$0.08
COMMON SHARES
Basic Shares Outstanding 2.250M 2.510M
Diluted Shares Outstanding 2.154M 2.510M

Balance Sheet

Concept 2023 Q1 2022 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments
YoY Change
Cash & Equivalents $200.1M $249.1M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables
Other Receivables
Total Short-Term Assets
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets
YoY Change
Total Long-Term Assets
YoY Change
TOTAL ASSETS
Total Short-Term Assets
Total Long-Term Assets
Total Assets $200.1M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable
YoY Change
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities
Total Long-Term Liabilities
Total Liabilities $68.44K
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings $0.00
YoY Change
Common Stock
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity
YoY Change
Total Liabilities & Shareholders Equity $200.1M
YoY Change

Cashflow Statement

Concept 2023 Q1 2022 Q1
OPERATING ACTIVITIES
Net Income -$205.4K -$699.1K
YoY Change -70.62% -19.87%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$210.8K -$702.1K
YoY Change -69.97% -19.86%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -19.28M 4.930M
YoY Change -491.01% -68.7%
NET CHANGE
Cash From Operating Activities -210.8K -702.1K
Cash From Investing Activities
Cash From Financing Activities -19.28M 4.930M
Net Change In Cash -16.97M 1.734M
YoY Change -1078.37% -145.17%
FREE CASH FLOW
Cash From Operating Activities -$210.8K -$702.1K
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2023Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2023Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2023Q1 dei Entity Registrant Name
EntityRegistrantName
Invesco CurrencyShares Swiss Franc Trust
CY2022Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2022Q4 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2023Q1 us-gaap Temporary Equity Par Or Stated Value Per Share
TemporaryEquityParOrStatedValuePerShare
CY2023Q1 dei Amendment Flag
AmendmentFlag
false
CY2023Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001353615
CY2023Q1 dei Document Type
DocumentType
10-Q
CY2023Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2023Q1 dei Document Period End Date
DocumentPeriodEndDate
2023-03-31
CY2023Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2023
CY2023Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2023Q1 dei Entity File Number
EntityFileNumber
001-32907
CY2023Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
NY
CY2023Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
20-4686336
CY2023Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
3500 Lacey Road
CY2023Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Suite 700
CY2023Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
Downers Grove
CY2023Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
IL
CY2023Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
60515
CY2023Q1 dei City Area Code
CityAreaCode
800
CY2023Q1 dei Local Phone Number
LocalPhoneNumber
983-0903
CY2023Q1 dei Security12b Title
Security12bTitle
Common Units of Beneficial Interest
CY2023Q1 dei Trading Symbol
TradingSymbol
FXF
CY2023Q1 dei Security Exchange Name
SecurityExchangeName
NYSEArca
CY2023Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2023Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2023Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2023Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2023Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2023Q1 dei Entity Shell Company
EntityShellCompany
false
CY2023Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
2050000
CY2023Q1 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
200064460
CY2022Q4 us-gaap Interest Bearing Deposits In Banks
InterestBearingDepositsInBanks
217032018
CY2023Q1 us-gaap Assets
Assets
200064460
CY2022Q4 us-gaap Assets
Assets
217032018
CY2023Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
68437
CY2022Q4 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
73878
CY2023Q1 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2022Q4 us-gaap Interest Payable Current
InterestPayableCurrent
0
CY2023Q1 us-gaap Liabilities
Liabilities
68437
CY2022Q4 us-gaap Liabilities
Liabilities
73878
CY2023Q1 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2050000
CY2023Q1 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2050000
CY2022Q4 us-gaap Temporary Equity Shares Issued
TemporaryEquitySharesIssued
2250000
CY2022Q4 us-gaap Temporary Equity Shares Outstanding
TemporaryEquitySharesOutstanding
2250000
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
1734269
CY2023Q1 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
199996023
CY2022Q4 us-gaap Redeemable Noncontrolling Interest Equity Carrying Amount
RedeemableNoncontrollingInterestEquityCarryingAmount
216958140
CY2023Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2022Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
0
CY2023Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
200064460
CY2022Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
217032018
CY2023Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2022Q1 us-gaap Investment Income Interest
InvestmentIncomeInterest
0
CY2023Q1 us-gaap Revenues
Revenues
0
CY2022Q1 us-gaap Revenues
Revenues
0
CY2023Q1 us-gaap Sponsor Fees
SponsorFees
205377
CY2022Q1 us-gaap Sponsor Fees
SponsorFees
240905
CY2023Q1 us-gaap Interest Expense
InterestExpense
-0
CY2022Q1 us-gaap Interest Expense
InterestExpense
458215
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
205377
CY2022Q1 us-gaap Operating Expenses
OperatingExpenses
699120
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-205377
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-699120
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.10
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.10
CY2022Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.08
CY2022Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.08
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2153889
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2153889
CY2022Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
2510000
CY2022Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
2510000
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-205377
CY2023Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
205377
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-699120
CY2022Q1 us-gaap Reclassifications Of Temporary To Permanent Equity
ReclassificationsOfTemporaryToPermanentEquity
699120
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-205377
CY2022Q1 us-gaap Net Income Loss
NetIncomeLoss
-699120
CY2023Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
0
CY2022Q1 us-gaap Increase Decrease In Interest Payable Net
IncreaseDecreaseInInterestPayableNet
-1971
CY2023Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-5441
CY2022Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
-1036
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-210818
CY2022Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-702127
CY2023Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
4832254
CY2022Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
9767381
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
24109763
CY2022Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
4837221
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-19277509
CY2022Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
4930160
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
2520769
CY2022Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-2493764
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-16967558
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
217032018
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
247388709
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
200064460
CY2022Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
249122978
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
0
CY2022Q1 us-gaap Interest Paid Net
InterestPaidNet
460186
CY2023Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2006-06-08
CY2006Q2 fxf Initial Incorporation Deposit With Bank Sponsor
InitialIncorporationDepositWithBankSponsor
100
CY2023Q1 fxf Number Of Deposits Accounts In Which Trust Assets Primarily Consist Demand Deposit
NumberOfDepositsAccountsInWhichTrustAssetsPrimarilyConsistDemandDeposit
2
CY2023Q1 fxf Stock Redeemable In Baskets Number Of Shares
StockRedeemableInBasketsNumberOfShares
50000
CY2023Q1 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">B. Accounting Estimates</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;">The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates by a significant amount. In addition, the Trust monitors for material events or transactions that may occur or become known after the period-end date and before the date the financial statements are issued.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:&quot;Times New Roman&quot;, serif;min-width:fit-content;"> </span></p>
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2023Q1 fxf Minimum Period Required To Stay For Tax Liability
MinimumPeriodRequiredToStayForTaxLiability
P183D
CY2023Q1 us-gaap Investment Interest Rate
InvestmentInterestRate
0.0000
CY2023Q1 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
4460171
CY2023Q1 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
22293358
CY2023Q1 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
195949
CY2023Q1 us-gaap Cash
Cash
182768887
CY2023Q1 us-gaap Cash
Cash
200064460
CY2022 us-gaap Proceeds From Issuance Of Redeemable Preferred Stock
ProceedsFromIssuanceOfRedeemablePreferredStock
205682665
CY2022 us-gaap Payments For Repurchase Of Redeemable Preferred Stock
PaymentsForRepurchaseOfRedeemablePreferredStock
227984526
CY2022 us-gaap Payments For Operating Activities
PaymentsForOperatingActivities
2308339
CY2022Q4 us-gaap Cash
Cash
200798023
CY2022Q4 us-gaap Cash
Cash
217032018
CY2023Q1 fxf Share Purchase And Redemptions Settlement Period Creation And Redemption
SharePurchaseAndRedemptionsSettlementPeriodCreationAndRedemption
P2D

Files In Submission

Name View Source Status
fxf-20230331_cal.xml Edgar Link unprocessable
R3.htm Edgar Link pending
0000950170-23-019017-index-headers.html Edgar Link pending
0000950170-23-019017-index.html Edgar Link pending
0000950170-23-019017.txt Edgar Link pending
0000950170-23-019017-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
fxf-20230331.htm Edgar Link pending
fxf-20230331.xsd Edgar Link pending
fxf-ex31_1.htm Edgar Link pending
fxf-ex31_2.htm Edgar Link pending
fxf-ex32_1.htm Edgar Link pending
fxf-ex32_2.htm Edgar Link pending
img245610745_0.jpg Edgar Link pending
img245610745_1.jpg Edgar Link pending
img245610745_2.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
fxf-20230331_def.xml Edgar Link unprocessable
fxf-20230331_lab.xml Edgar Link unprocessable
fxf-20230331_pre.xml Edgar Link unprocessable
fxf-20230331_htm.xml Edgar Link completed
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending